Publication List
Tanaka HY, Kitahara K, Sasaki N, Nakao N, Sato K, Narita H, Shimoda H, Matsusaki M, Nishihara H, Masamune A, Kano MR.
Biomaterials. 2018 Nov 17;192:355-367. doi: 10.1016/j.biomaterials.2018.11.023.
Trends in Polypharmacy in Japan: A Nationwide Retrospective Study.
Onoue H, Koyama T, Zamami Y, Hagiya H, Tatebe Y, Mikami N, Shinomiya K, Kitamura Y, Hinotsu S, Sendo T, Ouchi Y, Kano MR.
J Am Geriatr Soc. 2018 Oct 6. doi: 10.1111/jgs.15569.
Nishiguchi A, Matsusaki M, Kano MR, Nishihara H, Okano D, Asano Y, Shimoda H, Kishimoto S, Iwai S, Akashi M.
Biomaterials. 2018 Oct;179:144-155. doi: 10.1016/j.biomaterials.2018.06.019.
Teratani Y, Hagiya H, Koyama T, Adachi M, Ohshima A, Zamami Y, Tanaka HY, Tatebe Y, Tasaka K, Mikami N, Shinomiya K, Kitamura Y, Kano MR, Hinotsu S, Sendo T.
Fam Pract. 2018 Sep 29. doi: 10.1093/fampra/cmy094.
Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.
Tanaka HY, Kano MR.
Cancer Sci. 2018 Jul;109(7):2085-2092. doi: 10.1111/cas.13630.
若手アカデミー活動を考える
狩野光伸
学術の動向= Trends in the sciences 23 (5), 5_36-5_43, 2018
講演 若手アカデミー活動を考える: 持続的進化のためのインテグリティのある学術活動に向けて (科学と社会: 科学者の集まり (3))
狩野光伸
学術の動向= Trends in the sciences 23 (5), 36-43, 2018
Trends in incidence and mortality of tuberculosis in Japan: a population-based study, 1997-2016.
Hagiya H, Koyama T, Zamami Y, Minato Y, Tatebe Y, Mikami N, Teratani Y, Ohshima A, Shinomiya K, Kitamura Y, Sendo T, Hinotsu S, Tomono K, Kano MR.
Epidemiol Infect. 2018 Nov 9:1-10. doi: 10.1017/S095026881800290X.
Application of biomaterials in interdisciplinary approaches for cancer research
Y Baba, M Kano
CANCER SCIENCE 109, 146-146, 2018
Developing experimental models to analyze the behavior of Nano-DDSs within biological systems
MR Kano, HY Tanaka
CANCER SCIENCE 109, 148-148, 2018
岡山大学における全学的な SDGs 達成努力の開始
狩野光伸， 伊野英男， 横井篤文， 佐藤法仁， 高橋香代， 槇野博史
学術の動向 23 (1), 1_44-1_47, 2018
岡山大学における全学的な SDGs 達成努力の開始 (特集 国際連合 「持続可能な開発のためのアジェンダ 2030 (SDGs)」 と学術, 科学技術)--(日本の取り組み)
狩野光伸， 伊野英男， 横井篤文， 佐藤法仁， 高橋香代， 槇野博史
学術の動向= Trends in the sciences 23 (1), 44-47, 2018
Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest
Niimura T, Zamami Y, Koyama T, Izawa-Ishizawa Y, Miyake M, Koga T, Harada K, Ohshima A, Imai T, Kondo Y, Imanishi M, Takechi K, Fukushima K, Horinouchi Y, Ikeda Y, Fujino H, Tsuchiya K, Tamaki T, Hinotsu S, Kano MR, Ishizawa K.
Scientific reports 7 (1), 17919, 2017
日韓アカデミー若手科学者会合の報告
新福洋子， 狩野光伸
学術の動向 22 (9), 9_106-9_107, 2017
Desmoplastic Reaction in 3D‐Pancreatic Cancer Tissues Suppresses Molecular Permeability.
Michiya Matsusaki, Misaki Komeda, Simona Mura, Hiroyoshi Y Tanaka, Mitsunobu R Kano, Patrick Couvreur, Mitsuru Akashi.
Advanced healthcare materials.2017; 6 (15).
Regulation of endothelial Fas expression as a mechanism of promotion of vascular integrity by mural cells in tumors.
Ryosuke Kamei, Hiroyoshi Y Tanaka, Takao Kawano, Chiharu Morii, Sayaka Tanaka, Hiroshi Nishihara, Caname Iwata, Mitsunobu R Kano.
Cancer science. 2017;108 (5), 1080-1088.
Yu Matsumoto, Joseph W Nichols, Kazuko Toh, Takahiro Nomoto, Horacio Cabral, Yutaka Miura, R James Christie, Naoki Yamada, Tadayoshi Ogura, Mitsunobu R Kano, Yasuhiro Matsumura, Nobuhiro Nishiyama, Tatsuya Yamasoba, You Han Bae, Kazunori Kataoka.
Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery.
Nature nanotechnology. 2016;11 (6), 533.
Satoshi Sakai, Caname Iwata, Hiroyoshi Y Tanaka, Horacio Cabral, Yasuyuki Morishita, Kohei Miyazono, Mitsunobu R Kano.
Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2.
Journal of Controlled Release. 2016;230, 109-115.
Yasutaka Anraku, Akihiro Kishimura, Mako Kamiya, Sayaka Tanaka, Takahiro Nomoto, Kazuko Toh, Yu Matsumoto, Shigeto Fukushima, Daiki Sueyoshi, Mitsunobu R Kano, Yasuteru Urano, Nobuhiro Nishiyama, Kazunori Kataoka.
Systemically Injectable Enzyme‐Loaded Polyion Complex Vesicles as In Vivo Nanoreactors Functioning in Tumors.
Angewandte Chemie International Edition. 2016;55 (2), 560-565.
Hiroshi Nishihara, Mitsunobu R Kano.
Authentic Vascular and Stromal Structure in Animal Disease Model for Nanomedicine.
Intracellular Delivery III 2016;149-160.
Wataru Kawamura, Yutaka Miura, Daisuke Kokuryo, Kazuko Toh, Naoki Yamada, Takahiro Nomoto, Yu Matsumoto, Daiki Sueyoshi, Xueying Liu, Ichio Aoki, Mitsunobu R Kano, Nobuhiro Nishiyama, Tsuneo Saga, Akihiro Kishimura, Kazunori Kataoka.
Density-tunable conjugation of cyclic RGD ligands with polyion complex vesicles for the neovascular imaging of orthotopic glioblastomas.
Science and technology of advanced materials. 2015;16 (3), 035004.
Horacio Cabral, Jun Makino, Yu Matsumoto, Peng Mi, Hailiang Wu, Takahiro Nomoto, Kazuko Toh, Naoki Yamada, Yuriko Higuchi, Satoshi Konishi, Mitsunobu R Kano, Hiroshi Nishihara, Yutaka Miura, Nobuhiro Nishiyama, Kazunori Kataoka.
Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers.
ACS nano. 2015;9 (5), 4957-4967.
Kano MR.
Nano-pathophysiology: A novel integrated approach to disease through application of nanotechnology.
Adv Drug Deliv Rev. 2014; 74:1.
Wu H, Cabral H, Toh K, Mi P, Chen YC, Matsumoto Y, Yamada N, Liu X, Kinoh H, Miura Y, Kano MR, Nishihara H, Nishiyama N, Kataoka K.
Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with inflammation.
J Control Release. 2014;20;189C:1-10.
Ge Z, Chen Q, Osada K, Liu X, Tockary TA, Uchida S, Dirisala A, Ishii T, Nomoto T, Toh K, Matsumoto Y, Oba M, Kano MR, Itaka K, Kataoka K.
Targeted gene delivery by polyplex micelles with crowded PEG palisade and cRGD moiety for systemic treatment of pancreatic tumors.
Biomaterials. 2014; 35(10):3416-26.
Curtis DJ, Sood A, Phillips TJ, Leinster VH, Nishiguchi A, Coyle C, Lacharme-Lora L, Beaumont O, Kemp H, Goodall R, Cornes L, Giugliano M, Barone RA, Matsusaki M, Akashi M, Tanaka HY, Kano MR, McGarvey J, Halemani ND, Simon K, Keehan R, Ind W, Masters T, Grant S, Athwal S, Collett G, Tannetta D, Sargent IL, Scull-Brown E, Liu X, Aquilina K, Cohen N, Lane JD, Thoresen M, Hanley J, Randall A, Case CP.
Secretions from placenta, after hypoxia/reoxygenation, can damage developing neurones of brain under experimental conditions.
Exp Neurol. 2014; 261C:386-395.
Kano MR.
Nanotechnology and tumor microcirculation.
Adv Drug Deliv Rev. 2014; 74C:2-11.
Kongsmak K, Pungpit P, Kano MR, Komai S, Pyawattanametha W, Phanraksa O.
Perceptions of Research Excellence in Thailand and Japan.
STI Policy Rev. 2013; 4(2)113-135.
Miura Y, Takenaka T, Toh K, Wu S, Nishihara H, Kano MR, Ino Y, Nomoto T, Matsumoto Y, Koyama H, Cabral H, Nishiyama N, Kataoka K.
Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood-Brain Tumor Barrier.
ACS Nano. 2013.
Cabral H, Murakami M, Hojo H, Terada Y, Kano MR, Chung UI, Nishiyama N, Kataoka K.
Targeted therapy of spontaneous murine pancreatic tumors by polymeric micelles prolongs survival and prevents peritoneal metastasis.
Proc Natl Acad Sci U S A. 2013; 110(28):11397-402.
Kokuryo D, Anraku Y, Kishimura A, Tanaka S, Kano MR, Kershaw J, Nishiyama N, Saga T, Aoki I, Kataoka K.
SPIO-PICsome: Development of a highly sensitive and stealth-capable MRI nano-agent for tumor detection using SPIO-loaded unilamellar polyion complex vesicles (PICsomes).
J Control Release. 2013;169(3):220-7.
Wu S, Kasim V, Kano MR, Tanaka S, Ohba S, Miura Y, Miyata K, Liu X, Matsuhashi A, Chung UI, Yang L, Kataoka K, Nishiyama N, Miyagishi M.
Transcription factor YY1 contributes to tumor growth by stabilizing hypoxia factor HIF-1α in a p53-independent manner.
Cancer Res. 2013;73(6):1787-99.
Harada M, Iwata C, Saito H, Ishii K, Hayashi T, Yashiro M, Hirakawa K, Miyazono K, Kato Y, Kano MR.
NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo.
Int J Nanomedicine. 2012; 7:2713-27.
Zhang L, Nishihara H, Kano MR.
Pericyte-coverage of human tumor vasculature and nanoparticle permeability.
Biol Pharm Bull. 2012; 35(5):761-6.
Chen Q, Osada K, Ishii T, Oba M, Uchida S, Tockary TA, Endo T, Ge Z, Kinoh H, Kano MR, Itaka K, Kataoka K.
Homo-catiomer integration into PEGylated polyplex micelle from block-catiomer for systemic anti-angiogenic gene therapy for fibrotic pancreatic tumors.
Biomaterials. 2012; 33(18):4722-30.
Yuzawa S, Kano MR, Einama T, Nishihara H.
PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker.
Med Oncol. 2012; 29(4):2824-30.
Rafi M, Cabral H, Kano MR, Mi P, Iwata C, Yashiro M, Hirakawa K, Miyazono K, Nishiyama N, Kataoka K.
Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis.
J Control Release. 2012; 159(2):189-96.
Hosoya H, Kadowaki K, Matsusaki M, Cabral H, Nishihara H, Ijichi H, Koike K, Kataoka K, Miyazono K, Akashi M, Kano MR.
Engineering fibrotic tissue in pancreatic cancer: a novel three-dimensional model to investigate nanoparticle delivery.
Biochem Biophys Res Commun. 2012; 419(1):32-7.
Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano MR, Miyazono K, Uesaka M, Nishiyama N, Kataoka K.
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.
Nat Nanotechnol. 2011; 6(12):815-23.
Nakagome K, Imamura M, Kawahata K, Harada H, Okunishi K, Matsumoto T, Sasaki O, Tanaka R, Kano MR, Chang H, Hanawa H, Miyazaki J, Yamamoto K, Dohi M.
High Expression of IL-22 Suppresses Antigen-Induced Immune Responses and Eosinophilic Airway Inflammation via an IL-10-Associated Mechanism.
J Immunol. 2011; 187:5077-89.
Vachutinsky Y, Oba M, Miyata K, Hiki S, Kano MR, Nishiyama N, Koyama H, Miyazono K, Kataoka K.
Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micelles.
J Control Release 2011; 149: 51-57.
Oba M, Miyata K, Osada K, Christie RJ, Sanjoh M, Li W, Fukushima S, Ishii T, Kano MR, Nishiyama N, Koyama H, Kataoka K.
Polyplex micelles prepared from omega-cholesteryl PEG-polycation block copolymers for systemic gene delivery.
Biomaterials2011; 32: 652-663.
Murakami M, Cabral H, Matsumoto Y, Wu S, Kano MR, Yamori T, Nishiyama N, Kataoka K.
Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting.
Sci Transl Med 2011; 3: 64ra2.
Ehata S, Johansson E, Katayama R, Koike S, Watanabe A, Hoshino Y, Katsuno Y, Komuro A, Koinuma D, Kano MR, Yashiro M, Hirakawa K, Aburatani H, Fujita N, Miyazono K.
Transforming growth factor-beta decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells.
Oncogene 2011; 30: 1693-1705.
Sumida H, Noguchi K, Kihara Y, Abe M, Yanagida K, Hamano F, Sato S, Tamaki K, Morishita Y, Kano MR, Iwata C, Miyazono K, Sakimura K, Shimizu T, Ishii S.
LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis.
Blood 2010;116: 5060-5070.
Ota H, Eto M, Kano MR, Kahyo T, Setou M, Ogawa S, Iijima K, Akishita M, Ouchi Y.
Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway.
Arterioscler Thromb Vasc Biol 2010;30: 2205-2211.
Oba M, Vachutinsky Y, Miyata K, Kano MR, Ikeda S, Nishiyama N, Itaka K, Miyazono K, Koyama H, Kataoka K.
Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1.
Mol Pharm2010; 7: 501-509.
Kumagai M, Sarma TK, Cabral H, Kaida S, Sekino M, Herlambang N, Osada K, Kano MR, Nishiyama N, Kataoka K.
Enhanced in vivo Magnetic Resonance Imaging of Tumors by PEGylated Iron-Oxide-Gold Core-Shell Nanoparticles with Prolonged Blood Circulation Properties.
Macromol Rapid Commun 2010; 31: 1521-1528.
Johansson E, Komuro A, Iwata C, Hagiwara A, Fuse Y, Watanabe A, Morishita Y, Aburatani H, Funa K, *Kano MR, Miyazono K.
Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-beta-disrupted diffuse-type gastric carcinoma.
Cancer Sci 2010; 101:2398-2403.
Kumagai M, Kano M R, Morishita Y, Ota M, Imai Y, Nishiyama N, Sekino M, Ueno S, Miyazono K, Kataoka K.
Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-beta inhibitor.
J Control Release 2009; 140: 306-311.
Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y, Watanabe A, Aburatani H, Miyoshi H, Kiyono K, Shirai Y-, Suzuki H I, Hirakawa K, Kano M R, Miyazono K.
Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
J Natl Cancer Inst 2009; 101: 592-604.
Kiyono K, Suzuki H I, Morishita Y, Komuro A, Iwata C, Yashiro M, Hirakawa K, Kano M R, Miyazono K.
c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
Cancer Sci 2009; 100: 1809-1816.
Kiyono K, Suzuki H I, Matsuyama H, Morishita Y, Komuro A, Kano M R, Sugimoto K, Miyazono K.
Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells.
Cancer Res 2009; 69: 8844-8852.
Kano M R, Komuta Y, Iwata C, Oka M, Shirai Y-, Morishita Y, Ouchi Y, Kataoka K, Miyazono K.
Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-beta receptor inhibitor on extravasation of nanoparticles from neovasculature.
Cancer Sci 2009; 100: 173-180.
Han M, Oba M, Nishiyama N, Kano M R, Kizaka-Kondoh S, Kataoka K.
Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles.
Mol Ther 2009; 17: 1404-1410.
Wu S, Nishiyama N, Kano M R, Morishita Y, Miyazono K, Itaka K, Chung U-I, Kataoka K.
Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene.
Mol Ther 2008; 16: 1227-1234.
Ota H, Eto M, Kano M R, Ogawa S, Iijima K, Akishita M, Ouchi Y.
Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells.
Arterioscler Thromb Vasc Biol 2008; 28: 1634-1639.
Oka M, Iwata C, Suzuki H I, Kiyono K, Morishita Y, Watabe T, Komuro A, Kano M R, Miyazono K.
Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis.
Blood 2008; 111: 4571-4579.
Miyata K, Oba M, Kano M R, Fukushima S, Vachutinsky Y, Han M, Koyama H, Miyazono K, Nishiyama N, Kataoka K.
Polyplex micelles from triblock copolymers composed of tandemly aligned segments with biocompatible, endosomal escaping, and DNA-condensing functions for systemic gene delivery to pancreatic tumor tissue.
Pharm Res 2008; 25: 2924-2936.
Nakagome K, Dohi M, Okunishi K, Tanaka R, Kouro T, Kano M R, Miyazono K, Miyazaki J-, Takatsu K, Yamamoto K.
IL-5-induced hypereosinophilia suppresses the antigen-induced immune response via a TGF-beta-dependent mechanism.
J Immunol 2007;179: 284-294.
Kano M R, Bae Y, Iwata C, Morishita Y, Yashiro M, Oka M, Fujii T, Komuro A, Kiyono K, Kaminishi M, Hirakawa K, Ouchi Y, Nishiyama N, Kataoka K, Miyazono K.
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling.
Proc Natl Acad Sci U S A 2007; 104: 3460-3465.
Iwata C, Kano M R, Komuro A, Oka M, Kiyono K, Johansson E, Morishita Y, Yashiro M, Hirakawa K, Kaminishi M, Miyazono K.
Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
Cancer Res 2007; 67: 10181-10189.
Kano M R, Morishita Y, Iwata C, Iwasaka S, Watabe T, Ouchi Y, Miyazono K, Miyazawa K.
VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.
J Cell Sci 2005; 118: 3759-3768.
和文論文・総説
狩野光伸 若 手科学者によるアカデミー活動の国内外における取り組み 平成25年度 文部科学省委託調査研究「科学技術イノベーション政策における『政策のた めの科学』の推進に向けた試行的実践」報 告書 国立大学法人政策研究大学院大学 2014
狩野光伸・田中さやか 腫瘍血管を通じた薬剤送達 最新医学 2013:68(12)
狩野光伸・田中由浩 オ ランダにおける取り組みについて 学術の動向 特集「若者たちとソウゾウする、私たちそして我が国の未来―日本学術会議若手アカデミー委員会の挑 戦―」 2012
狩野光伸 細胞積層培養法を用いてヒト膵癌間質を模した実験系を構築する 化学と工業 2012
狩野光伸 Theranosticsプローブ Drug Delivery System 2011:26(4)
狩野光伸 医学部でリサーチマインドを育てるには？―東京大学医学部MD研 究者育成プログラムの試み 週間医学界新聞 2009: 2855; 2
狩野光伸 腫瘍血管正常化と血管壁細胞 血管医学 2009:10(4)349-355
狩野光伸・宮園浩平 EMT制御と分子標的薬 実験医学2009:27(5)653-660
狩野光伸 腫瘍発育、血管新生、治療反応性への動脈硬化と血管老化の影響 分子細胞治療2008:7(1)79-80
狩野光伸・宮園浩平 血管におけるTGF-β ファミリーシグナル 医学のあゆみ2008:223(12); 1037-1042
狩野光伸 TGF-β シグナルの制御と癌治療．細胞2007：39(8); 31-33
狩野光伸 ナノ粒子抗癌剤と低用量TGF-β 阻害剤の併用による難治癌治療．実験医学 2007:25(9); 1344-1347
狩野光伸・宮園浩平 腫瘍血管新生を標的とした癌治療. 実験医学増刊号「急速進展する血管研究」2006:24(18); 2858-2864
BaeYounsoo・狩野光伸・西山伸宏・宮園浩平・片岡一則 環境応答性高分子ミセル薬物キャリアとTGF-bシグナル阻害剤の併用による効果的な難治性
固形癌の治療. Drug Delivery System 2006:21(3); 327
狩野光伸・ 宮園浩平 血管新生におけるTGF-β スーパーファミリーシグナルの関与. Molecular Medicine 2005:42;661-668.
狩野光伸・ 高尾信廣 ショックの輸液と注意．臨床看護 2002.
丸山正隆・佐藤孝道・大東誠司・蝶名林直彦・福井準之助・佐久間一穂・細谷亮太・西田知佳子・伊達暢子・関口建次・狩野光伸・古川恵一・日野
原重明・櫻井健司・岡田定 Terminal Care Conference 院内シンポジウム/当院におけるがん告知のあり方を考える（後編） Journal of Integrated
Medicine 2002: 12(5); 461-467
丸山正隆・佐藤孝道・大東誠司・蝶名林直彦・福井準之助・佐久間一穂・細谷亮太・西田知佳子・伊達暢子・関口建次・狩野光伸・古川恵一・日野
原重明・櫻井健司・岡田定 Terminal Care Conference 院内シンポジウム/当院におけるがん告知のあり方を考える（前編） Journal of Integrated
Medicine 2002: 12(4); 359-371
寺田秀夫・狩野光伸・ 長浜正彦・岡田定・小松康宏・松井征男、HCV-Carrierに みられたSLEに 続発した混合型クリオグロブリン血症，AIHA， 橋本
病など多彩な病態を呈した１例、血液フロンティア 2002:12(5) 692-
松本明子・青島正大・小松康宏・井部俊子・西田知佳子・金学粋・内山伸・狩野光伸・蝶名林直彦・太田大介他 Terminal Care Conference 透析・人工
呼吸器に長期間依存し急変を繰り返す53歳 女性 Journal of Integrated Medicine 2001: 11(4); 373-382
狩野光伸・寺田秀夫・岡田定 SLEに続発したクリオグロブリン血症とAIHAの1例 臨床血液2001:42(2);123
狩野光伸・高尾信廣 体液量の指標を探る. 聖路加健康科学誌 2001:9;47-50
和文書物
狩野光伸 論理的な考え方伝え方－根拠に基づく正しい論議のために（慶応義塾大学出版会）2015年
狩野光伸（訳） 9章 血管新生 デヴィータがんの分子生物学 （監訳：宮園浩平、石川冬木、間野博行 メディカルサイエンスインターナショナル）
2012年
狩野光伸 研究者に適した「自分」を発見した あなたへの医師キャリアガイダンス（編集：岡田定 堀之内秀仁 藤井健夫、医学書院） 2012年
岡田 定、平澤俊明、狩野光伸、内山 伸. 臨床研修ルールブック （三輪書店） 2003年